• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rethinking sepsis after a two-year battle with COVID-19.

作者信息

Zhang Yingying, Han Jiahuai

机构信息

State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian, China.

Laboratory Animal Center, Xiamen University, Xiamen, Fujian, China.

出版信息

Cell Mol Immunol. 2022 Nov;19(11):1317-1318. doi: 10.1038/s41423-022-00909-7. Epub 2022 Sep 1.

DOI:10.1038/s41423-022-00909-7
PMID:36050479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9434097/
Abstract
摘要

相似文献

1
Rethinking sepsis after a two-year battle with COVID-19.在与新冠病毒斗争两年后对脓毒症的重新思考。
Cell Mol Immunol. 2022 Nov;19(11):1317-1318. doi: 10.1038/s41423-022-00909-7. Epub 2022 Sep 1.
2
Rethinking the CDC's pneumonia secondary bloodstream infection attribution criteria during the COVID-19 pandemic for patients with fungal pneumonia.重新思考疾病控制与预防中心（CDC）在新冠疫情期间针对真菌性肺炎患者的肺炎继发性血流感染归因标准。
J Hosp Infect. 2022 Aug;126:128-129. doi: 10.1016/j.jhin.2022.04.003. Epub 2022 Apr 14.
3
Why does the sepsis induced by severe COVID-19 have different clinical features from sepsis induced by CrKP?为何重症新型冠状病毒肺炎所致脓毒症与肺炎克雷伯菌所致脓毒症具有不同的临床特征？
Chin J Traumatol. 2022 Jan;25(1):25-26. doi: 10.1016/j.cjtee.2021.11.005. Epub 2021 Dec 1.
4
Therapeutic potential of megadose vitamin C to reverse organ dysfunction in sepsis and COVID-19.大剂量维生素 C 逆转脓毒症和 COVID-19 器官功能障碍的治疗潜力。
Br J Pharmacol. 2021 Oct;178(19):3864-3868. doi: 10.1111/bph.15579. Epub 2021 Jun 24.
5
Comparison of Cytokine Hemadsorption as an Immunomodulator Therapy in COVID-19 Patients with and without Bacterial Sepsis.比较细胞因子吸附作为 COVID-19 合并与不合并细菌感染患者的免疫调节剂治疗。
Clin Lab. 2022 Oct 1;68(10). doi: 10.7754/Clin.Lab.2022.211249.
6
Severe COVID-19-associated sepsis is different from classical sepsis induced by pulmonary infection with carbapenem-resistant klebsiella pneumonia (CrKP).严重 COVID-19 相关脓毒症与由耐碳青霉烯肺炎克雷伯菌（CrKP）引起的肺部感染所致经典脓毒症不同。
Chin J Traumatol. 2022 Jan;25(1):17-24. doi: 10.1016/j.cjtee.2021.11.001. Epub 2021 Nov 15.
7
Clinical sepsis phenotypes in critically ill COVID-19 patients.危重症 COVID-19 患者的临床脓毒症表型。
Crit Care. 2022 Aug 9;26(1):244. doi: 10.1186/s13054-022-04118-6.
8
Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach.通过生物信息学和系统生物学方法发现 COVID-19 和脓毒症之间的共同发病机制。
Front Immunol. 2022 Aug 31;13:975848. doi: 10.3389/fimmu.2022.975848. eCollection 2022.
9
Sepsis and mediator-directed therapy: rethinking the target populations. Mediator-directed therapy in sepsis: rethinking the target populations. Toronto, Canada, 31 October-1 November 1998.脓毒症与介质导向治疗：对目标人群的重新思考。脓毒症中的介质导向治疗：对目标人群的重新思考。1998年10月31日至11月1日于加拿大多伦多
Mol Med Today. 1999 Feb;5(2):56-8. doi: 10.1016/s1357-4310(98)01413-0.
10
The Association of TSH and Thyroid Hormones With Lymphopenia in Bacterial Sepsis and COVID-19.促甲状腺激素（TSH）和甲状腺激素与细菌性败血症和 COVID-19 中淋巴细胞减少症的关系。
J Clin Endocrinol Metab. 2021 Jun 16;106(7):1994-2009. doi: 10.1210/clinem/dgab148.

引用本文的文献

1
Unpacking the sepsis controversy.剖析脓毒症争议
Trauma Surg Acute Care Open. 2025 Mar 4;10(1):e001733. doi: 10.1136/tsaco-2024-001733. eCollection 2025.
2
The application of metagenomics, radiomics and machine learning for diagnosis of sepsis.宏基因组学、放射组学和机器学习在脓毒症诊断中的应用。
Front Med (Lausanne). 2024 Sep 20;11:1400166. doi: 10.3389/fmed.2024.1400166. eCollection 2024.
3
PD-L1: From cancer immunotherapy to therapeutic implications in multiple disorders.程序性死亡受体配体1：从癌症免疫疗法到在多种疾病中的治疗意义
Mol Ther. 2024 Dec 4;32(12):4235-4255. doi: 10.1016/j.ymthe.2024.09.026. Epub 2024 Sep 28.
4
Bacteria-derived extracellular vesicles: endogenous roles, therapeutic potentials and their biomimetics for the treatment and prevention of sepsis.细菌衍生的细胞外囊泡：内源性作用、治疗潜力及其仿生学在脓毒症治疗和预防中的应用。
Front Immunol. 2024 Feb 13;15:1296061. doi: 10.3389/fimmu.2024.1296061. eCollection 2024.
5
Anthrax lethal toxin and tumor necrosis factor-α synergize on intestinal epithelia to induce mouse death.炭疽致死毒素和肿瘤坏死因子-α协同作用于肠道上皮细胞，导致小鼠死亡。
Protein Cell. 2024 Feb 1;15(2):135-148. doi: 10.1093/procel/pwad050.
6
Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions.细胞色素 P450 2C9 在 COVID-19 治疗中的作用：现状与未来方向。
Eur J Drug Metab Pharmacokinet. 2023 May;48(3):221-240. doi: 10.1007/s13318-023-00826-8. Epub 2023 Apr 24.
7
Role of the microbiota-gut-brain axis in postacute COVID syndrome.肠道菌群-肠-脑轴在新冠后综合征中的作用。
Am J Physiol Gastrointest Liver Physiol. 2023 Apr 1;324(4):G322-G328. doi: 10.1152/ajpgi.00293.2022. Epub 2023 Mar 7.
8
Extracellular Vesicles: New Players in the Mechanisms of Sepsis- and COVID-19-Related Thromboinflammation.细胞外囊泡：脓毒症和 COVID-19 相关血栓炎症机制中的新角色。
Int J Mol Sci. 2023 Jan 18;24(3):1920. doi: 10.3390/ijms24031920.

本文引用的文献

1
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials.抗病毒疗法治疗 COVID-19 的疗效：一项随机对照试验的系统评价。
BMC Infect Dis. 2022 Jan 31;22(1):107. doi: 10.1186/s12879-022-07068-0.
2
Single-cell multi-omics analysis of the immune response in COVID-19.单细胞多组学分析 COVID-19 中的免疫反应。
Nat Med. 2021 May;27(5):904-916. doi: 10.1038/s41591-021-01329-2. Epub 2021 Apr 20.
3
Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients.COVID-19 重症患者的细胞类型特异性免疫失调。
Cell Rep. 2021 Jan 5;34(1):108590. doi: 10.1016/j.celrep.2020.108590. Epub 2020 Dec 16.
4
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.血小板病和血管内皮病：COVID-19 血栓炎症的重要促成因素。
Nat Rev Cardiol. 2021 Mar;18(3):194-209. doi: 10.1038/s41569-020-00469-1. Epub 2020 Nov 19.
5
Animal models for COVID-19.用于 COVID-19 的动物模型。
Nature. 2020 Oct;586(7830):509-515. doi: 10.1038/s41586-020-2787-6. Epub 2020 Sep 23.
6
Eicosanoids: The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)?类二十烷酸：2019 年冠状病毒病（COVID-19）中被忽视的风暴？
Am J Pathol. 2020 Sep;190(9):1782-1788. doi: 10.1016/j.ajpath.2020.06.010. Epub 2020 Jul 8.
7
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).新型冠状病毒病（COVID-19）患者 T 细胞减少和功能耗竭。
Front Immunol. 2020 May 1;11:827. doi: 10.3389/fimmu.2020.00827. eCollection 2020.
8
Functional exhaustion of antiviral lymphocytes in COVID-19 patients.新冠病毒肺炎患者抗病毒淋巴细胞的功能耗竭
Cell Mol Immunol. 2020 May;17(5):533-535. doi: 10.1038/s41423-020-0402-2. Epub 2020 Mar 19.
9
Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients.外周血中T细胞的疲惫水平升高和功能多样性降低可能预示着新冠病毒疾病（COVID-19）患者病情的严重进展。
Cell Mol Immunol. 2020 May;17(5):541-543. doi: 10.1038/s41423-020-0401-3. Epub 2020 Mar 17.
10
Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): An International Expert Consensus Initiative for Improvement of Animal Modeling in Sepsis.临床前期脓毒症研究的最低质量阈值 (MQTiPSS)：改善脓毒症动物模型的国际专家共识倡议。
Shock. 2018 Oct;50(4):377-380. doi: 10.1097/SHK.0000000000001212.